Side Effect Management
Higher Risk of Thyroid Cancer Among Those With Breast Cancer History
March 11th 2015According to a recent analysis of a large national database, patients with a history of breast cancer have a higher risk of developing thyroid cancer than the general population, particularly if they receive adjuvant radiation therapy.
Chemobrain—It's Real, It's Complex, and the Science Is Still Evolving
February 17th 2015Talk with almost any cancer survivor, and he or she is likely to bring up the topic of "chemobrain," that fuzzy, murky state that patients blame for impaired memory. A review of the research shows how we're focusing on the problem.
Jenna Forsythe Gives Advice to Patients Newly Diagnosed with Cancer
January 27th 2015Jenna Forsythe, an oncology nurse at John Theurer Cancer Center in Hackensack, New Jersey, says many patients newly diagnosed with cancer will need to allow themselves to lean on their medical team, especially in regards to symptom management.
Adjusted Regimen of Abraxane and Gemzar Less Toxic in Pancreatic Cancer
January 20th 2015Changing the administration schedule for Gemzar (gemcitabine) plus Abraxane (nab-paclitaxel) from weekly to every other week significantly reduced side effects without impacting efficacy as a frontline treatment for patients with metastatic pancreatic cancer, according to a retrospective study presented at the 2015 GI Cancers Symposium.
How prevalent are long-term and late effects in survivors?
November 7th 2014The numbers of those who will be affected by long-term and late effects are difficult to determine because, in many cases, each cancer or treatment is accompanied by its own list of issues, which survivors may or may not experience.